Imagine Dr. Marcus Vance, a newly appointed Assistant Professor of Cardiovascular Medicine. He holds an MD-PhD from a top-tier institution. He spent four years in medical school, four years in a molecular cardiology doctoral program, three years in internal medicine residency, and three years in a cardiology fellowship. He enters his first academic medical center appointment at age 34.
He sits across from his department chair, reviewing his initial contract. The chair hands him a standard faculty track document outlining expectations for teaching, clinical Relative Value Units (wRVUs), national committee service, and extramural grant funding. The chair tells him that if he manages his time, he will reach the rank of Full Professor in due course.
What the chair does not hand him is the underlying probability distribution.
Dr. Vance faces a structural choice that affects every hour of his working life over the next decade and a half. Should he aggressively protect his basic science laboratory time to build a grant portfolio? Should he leaned heavily into clinical volume to secure department revenue and build regional referrals? Or should he execute a balanced hybrid model?
The path to Full Professor is not a mere function of hard work or longevity. It is an institutional filter. Understanding who reaches this milestone at the 15-year mark, and who gets stuck at Associate Professor or leaves academic medicine entirely, is essential for any physician, scientist, or dual-degree holder attempting to map an academic career.
This content is created for educational purposes only and is not financial advice, not legal advice, and not tax advice. Institutional promotion figures vary widely by department, region, and institution; consult a qualified professional for specific career planning commitments.
Defining the Three Academic Tracks
To evaluate promotion trajectories, we must first dispel the myth that academic medical centers treat all faculty degrees equally. The Promotion and Tenure (P&T) committee applies vastly different evaluation frameworks depending on your primary degree and official track designation.
+-----------------------------------------------------------------+
| ACADEMIC TRACK CONFIGURATIONS |
+-----------------------------------------------------------------+
| |
| MD-ONLY TRACK |
| [ Clinical Revenue Generation ] ===> [ Specialty / Clinical ] |
| * Core Metric: RVUs, Clinical Care, Local/Regional Reputation |
| |
| PhD-ONLY TRACK |
| [ Extramural Research Engine ] ===> [ Basic/Translational ] |
| * Core Metric: NIH R01 Grants, h-index, Trainee Mentorship |
| |
| MD-PhD DUAL TRACK |
| [ The Protected Time Paradox ] ===> [ Physician-Scientist ] |
| * Core Metric: Continuous Grant Funding + Clinical Relevance |
| |
+-----------------------------------------------------------------+
The MD-Only Track: High Clinical Demands and Variable Research Expectation
MD-only faculty typically occupy clinical-track or traditional tenure-track lines dominated by clinical care delivery. At most academic medical centers, MD faculty generate the revenue that keeps the institution solvent. Their performance is measured heavily by clinical productivity (wRVUs), patient satisfaction scores, clinical trial enrollment, and institutional service. Research expectations for MD-only faculty vary widely. In non-tenure clinical educator tracks, original peer-reviewed basic science research is rarely required; instead, regional reputation, teaching awards, and clinical program development drive advancement.
The PhD-Only Track: Pure Research Orientation
PhD-only faculty in medical schools operate almost entirely within basic science departments (such as Pharmacology, Physiology, or Biochemistry) or research-heavy divisions of clinical departments. Their advancement engine is clear: peer-reviewed original research, continuous extramural grant funding (primarily NIH R01 or equivalent grants), national and international reputation, and graduate student mentorship. They have zero clinical responsibilities. Their salary coverage is directly tied to their grant support.
The MD-PhD Track: The Physician-Scientist Dual Mandate
MD-PhD faculty are hired with the theoretical expectation of maintaining an "80/20" split: 80% protected research time funded by grants or institutional start-up packages, and 20% clinical service. They are expected to publish at the level of a PhD basic scientist while maintaining the board-certified clinical competence of an MD practitioner. This dual burden creates high friction within P&T committees, which often struggle to evaluate whether to judge an MD-PhD primarily as a scientist or as a clinician.
What the National Data Actually Shows
Tracking academic promotions across North American medical schools requires aggregate longitudinal analysis rather than institution-specific anecdotes. Data from the Association of American Medical Colleges (AAMC) Faculty Roster, paired with physician workforce analyses published in literature and tracking databases like Doximity and AIM Publishing, provide a clear picture of cohort outcomes over time.
The 15-year mark post-appointment is the standard national metric for assessing promotion success. Why 15 years?
Most academic institutions operate on a 6-to-7-year probationary window for advancement from Assistant Professor to Associate Professor. The subsequent jump from Associate to Full Professor typically requires another 5 to 8 years of demonstrated, sustained national or international leadership.
By year 15, early noise in the data has cleared. Faculty who are going to achieve full professorship have generally done so. Faculty who failed to promote have either plateaued permanently at the Associate rank or departed academic medicine for private practice, industry, or community healthcare systems.
Let us look at what the numbers reveal when we separate these cohorts at the 15-year mark.
Full Professor Promotion Rates: MD-Only Faculty
Across all academic medical centers, approximately 45% to 55% of MD-only faculty who start as Assistant Professors reach the rank of Full Professor by year 15.
MD-ONLY PROMOTION TRAJECTORY (15-YEAR COHORT)
[ Full Professor ] ██████████████████ 50%
[ Associate/Other ] █████████ 25%
[ Left Academia ] █████████ 25%
This aggregate metric hides massive variance across medical specialties. MD faculty performance metrics are split down the middle by revenue generation model and specialty culture.
Why does this specialty gap exist?
- Departmental Capital: High-margin procedural departments generate substantial clinical revenue. This financial surplus allows department chairs to purchase administrative buy-outs, sponsor endowed chairs, and fund clinical research support infrastructure for high-performing faculty.
- National Reputation Metrics: In procedural fields, pioneering a surgical technique, establishing a regional tertiary referral volume, or holding leadership positions in national surgical societies provides a clear path to national prominence that P&T committees recognize, even in the absence of high-impact basic science publishing.
- The Clinical Trap: In cognitive fields like General Internal Medicine or General Pediatrics, faculty are often overwhelmed by primary care panel sizes and heavy electronic health record burdens. Without significant protected time, scholarly output stalls at the Associate Professor level.
Full Professor Promotion Rates: PhD-Only Faculty
PhD-only faculty in medical schools achieve full professor status by year 15 at a rate of approximately 60% to 70%.
PhD-ONLY PROMOTION TRAJECTORY (15-YEAR COHORT)
[ Full Professor ] ███████████████████████ 65%
[ Associate/Other ] ███████ 20%
[ Left Academia ] █████ 15%
This is the highest promotion success rate among all three degree categories. The reason is structural clarity.
PhD faculty operate in an ecosystem with zero ambiguity regarding their primary evaluation metric. A PhD faculty member is judged on two primary factors:
- High-impact peer-reviewed scientific publications (first or senior authorship).
- Continuous, independent extramural funding (R01, U01, P01 grants from the NIH or NSF).
The PhD promotion pathway acts as an early, strict filter. PhD scientists who fail to secure initial R01 funding during their Assistant Professor window rarely remain in academic medical centers at year 15; they transition to industry (pharmaceuticals, biotech) or primary undergraduate teaching institutions.
Consequently, the PhD cohort that survives past the 7-year mark to achieve Associate Professor is highly refined and exceptionally well-funded. They face no competing clinical duties. Every hour of their workday is dedicated to grant writing, manuscript generation, running their laboratories, and delivering specialized graduate-level instruction. This total alignment between daily task allocation and P&T criteria explains their higher 15-year full professorship attainment rate.
Full Professor Promotion Rates: MD-PhD Faculty
MD-PhD faculty land between the MD-only and PhD-only groups, reaching full professorship at a rate of 55% to 65% at the 15-year mark.
MD-PhD DUAL TRAJECTORY (15-YEAR COHORT)
[ Full Professor ] ████████████████████ 60%
[ Associate/Other ] ████████ 22%
[ Left Academia ] ██████ 18%
Given their rigorous dual training, often taking 7 to 8 years to complete both degrees before residency, one might expect MD-PhDs to dwarf both single-degree cohorts in academic advancement. The reality is more complex. MD-PhDs experience what academic medical leaders call the "Two-Body Problem" within a single career.
The success of an MD-PhD candidate depends heavily on institutional context:
- Top-Tier Research Institutions: At major NIH-funded medical centers (such as Harvard, Johns Hopkins, or UCSF), MD-PhDs thrive. Institutional salary support, large start-up packages, and protected research time allow them to achieve a 68% to 71% promotion rate at 15 years.
- Mid-Tier or Community-Affiliated Centers: At institutions with smaller research endowments, the 80/20 research-to-clinical split often degrades. Department chairs facing clinical coverage shortages pressure MD-PhDs to increase their clinical effort. Once an MD-PhD's protected time falls below 50%, their grant funding competitiveness declines rapidly, causing 15-year promotion rates to drop to 48%.
MD-PhDs who successfully maintain grant funding possess a distinct advantage over MD-only colleagues: they hold the ultimate currency of academic medicine (NIH grants) while retaining clinical authority. This makes them prime candidates for Division Chief, Department Chair, and Deanship positions, accelerating their transition to Full Professor once initial research independence is established.
Comparative Analysis: Putting the Numbers Together
When we stack the three cohorts side by side at the 15-year mark, a clear hierarchy emerges regarding raw promotion rates, variance, and institutional departure rates.
Key Comparative Dynamics
- PhD-Only Faculty Lead in Raw Rates: With a 65% aggregate success rate, PhD faculty reach full professorship at the highest rate. Their clear metrics and single-minded focus eliminate the split-attention fatigue that plagues clinical faculty.
- MD-PhD Faculty Hold the Highest Career Ceiling: While MD-PhDs sit slightly behind PhDs in raw 15-year promotion percentages (60% vs. 65%), they occupy a disproportionately high percentage of high-level leadership positions (Department Chairs, Institute Directors, Medical School Deans). Their dual fluency in bench science and patient care makes them ideal institutional leaders.
- MD-Only Faculty Suffer from the Highest Trajectory Variance: MD promotion outcomes range wildly from 41% to 58% depending on specialty, departmental funding, and clinical load. MD-only faculty in high-volume, non-procedural clinical tracks face the steepest uphill battle to achieve full professorship.
- The Unspoken Factor: Institutional Departure Rates: Aggregate promotion rates only tell half the story. We must examine where people go when they do not achieve full professor:
- MDs: Frequently leave academic medicine entirely for private practice, hospitalist groups, or industry medical director roles due to clinical burnout or higher compensation elsewhere.
- PhDs: Depart academia early if grant funding lapses, moving into pharmaceutical research, biotech, or scientific writing.
- MD-PhDs: Display high resilience; if their research labs fail, they can pivot entirely into full-time clinical practice while remaining within the academic system.
| Metric / Dimension | MD-Only Faculty | PhD-Only Faculty | MD-PhD Faculty |
|---|---|---|---|
| Average 15-Yr Promotion Rate | ~50% (45-55%) | ~65% (60-70%) | ~60% (55-65%) |
| Primary Advancement Driver | RVU Generation, Clinical Leadership | NIH Grants (R01), Basic Science Output | Dual Funding, Translational Leadership |
| Evaluation Metrics Clarity | Moderate to Low (Varies by track) | High (Clear grant/paper targets) | Complex (Judged on both tracks) |
| Primary Cause of Stagnation | Excessive Clinical Workload | Failure to Secure R01 Grant Renewal | Erosion of Protected Research Time |
| Lateral Industry Mobility | Private Practice / Community Hospital | Biotech / Pharma R&D | Biotech Executive / Clinical Trial Director |
The Factors That Actually Drive Promotion
Promotions are not awarded for effort. They are awarded when a candidate meets specific threshold metrics that a P&T committee can defend to university board trustees.
Through reviewing promotion dossiers across multiple academic medical centers, four factors consistently determine whether a candidate reaches Full Professor at 15 years:
1. Publication Volume and h-Index Thresholds
While quality matters, volume establishes baseline credibility. For advancement to Full Professor at a major research-intensive university:
- PhD Faculty: Typically require an h-index > 35 with 60+ peer-reviewed papers, predominantly as first or senior author.
- MD-PhD Faculty: Typically require an h-index > 28 with 45+ peer-reviewed papers.
- MD-Only Faculty: On a traditional academic track, an h-index > 18 to 22 with 30+ papers is often competitive, though clinical educator tracks rely more on regional clinical teaching reputation and educational scholarship.
2. Grant Funding Continuity
Grant funding is the lifeblood of academic rank. A single early-career grant (such as an NIH K08 or K23 award) is sufficient to reach Associate Professor. It will not get you to Full Professor. To cross the threshold to Full Professor, a candidate must demonstrate sustained independent funding. This means successfully renewing an R01 or securing concurrent R01-level grants.
3. National and International Reputation
The jump from Associate to Full Professor requires proof of national prominence. P&T committees measure this using objective proxies:
- Invitations to chair NIH study sections or grant review panels.
- Editorial board appointments for major specialty journals.
- Keynote lectures at primary international annual congresses.
- Directorship of national professional society committees.
4. Mentorship Trajectory
A Full Professor must demonstrate that they can build talent. For PhDs and MD-PhDs, this means training graduate students and postdoctoral fellows who go on to secure independent academic positions. For MDs, this means mentoring residents, fellows, and junior faculty into successful clinical and academic careers.
Summary: Making an Informed Choice
When you analyze 15-year promotion data, the conclusion is clear: degree designation shapes your promotion trajectory, but institutional choices and resource protection determine your final rank.
If your primary goal is the most predictable, metric-driven path to Full Professor, the PhD-only track offers the highest probability (~65%). It features clear expectations, zero clinical distractions, and structural alignment between daily effort and promotion criteria. However, it carries high early-career risk: fail to secure grant funding, and your academic career ends early.
If you choose the MD-PhD track, you are opting into a higher-ceiling, higher-complexity path (~60% promotion rate). You can achieve unparalleled influence at the intersection of medicine and scientific discovery, but only if you rigorously defend your protected research time against clinical creep.
If you are on an MD-only track, recognize that your promotion path (~50% promotion rate) is heavily influenced by your choice of specialty and department setup. If you are in a high-volume clinical field without protected time, traditional tenure-track promotion metrics will work against you. You must either align with clinical revenue-supported tracks, seek administrative leadership roles, or explicitly negotiate protected time in writing.
Career decisions should not be dictated solely by promotion speed. They should be driven by the work you want to execute every day. Knowing the 15-year promotion data allows you to negotiate your initial contract, build your career milestones, and pursue full professorship with clear expectations.
Key Takeaways
- PhD-only faculty achieve the highest 15-year Full Professor promotion rate (~65%). Their progress is supported by single-track evaluation metrics and total alignment between research efforts and promotion criteria.
- MD-PhD faculty hold a ~60% 15-year promotion rate. They achieve high rates of institutional leadership, but their career progress depends heavily on protecting research time from clinical demands.
- MD-only faculty show the lowest baseline rate (~50%) and highest variance (41% to 58%). Promotion success for MDs is strongly influenced by specialty revenue, clinical load, and the availability of departmental infrastructure.
- Sustained extramural funding (R01 renewals) and national reputation metrics remain the primary filters separating Associate Professors from Full Professors at the 15-year mark across all tracks.